Amicogen Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Amicogen to acquire stake in KUMHO CHEMICAL INDUSTRY
Amicogen Inc:To acquire 69.54 pct stake (215,575 shares) in KUMHO CHEMICAL INDUSTRY LTD, which is engaged in manufacturing and sales of amino acid powder, to improve competitiveness.Transaction amount of 900 mln won.Expected transaction date of May 7.
Latest Key Developments in Biotechnology
- Immunomedics announces Orphan Drug designation for Veltuzumab for treatment of Pemphigus
- Neptune Technologies & Bioressources Inc appoints President & CEO
- Proteo Inc and Proteo Biotech AG announces final analysis of phase II clinical study on Elafin in Coronary Artery Bypass Surgery Completed
- Novogen Limited announces identification of lead ATM drug candidate
- Share this
- Digg this